<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title></journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2015.4287</article-id>
<article-id pub-id-type="publisher-id">mmr-12-05-6577</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Expression of leukemia inhibitory factor in the rat retina following acute ocular hypertension</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>HU</surname><given-names>QIANQIAN</given-names></name><xref rid="af1-mmr-12-05-6577" ref-type="aff">1</xref><xref rid="af2-mmr-12-05-6577" ref-type="aff">2</xref><xref rid="fn1-mmr-12-05-6577" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>HUANG</surname><given-names>CHANGQUAN</given-names></name><xref rid="af1-mmr-12-05-6577" ref-type="aff">1</xref><xref rid="af2-mmr-12-05-6577" ref-type="aff">2</xref><xref rid="fn1-mmr-12-05-6577" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>WANG</surname><given-names>YAO</given-names></name><xref rid="af1-mmr-12-05-6577" ref-type="aff">1</xref><xref rid="af3-mmr-12-05-6577" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author">
<name><surname>WU</surname><given-names>RENYI</given-names></name><xref rid="af1-mmr-12-05-6577" ref-type="aff">1</xref><xref rid="af2-mmr-12-05-6577" ref-type="aff">2</xref><xref ref-type="corresp" rid="c1-mmr-12-05-6577"/></contrib></contrib-group>
<aff id="af1-mmr-12-05-6577">
<label>1</label>Department of Glaucoma, Xiamen University Affiliated Eye Center, Xiamen, Fujian 361001, P.R. China</aff>
<aff id="af2-mmr-12-05-6577">
<label>2</label>Eye Institute of Xiamen University, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361001, P.R. China</aff>
<aff id="af3-mmr-12-05-6577">
<label>3</label>Department of Ophthalmology, First Hospital of Xi'an, Shaanxi Institute of Ophthalmology, Shaanxi Provincial Key Lab of Ophthalmology, Xi'an, Shaanxi 710002, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-12-05-6577">Correspondence to: Professor Renyi Wu, Department of Glaucoma, Xiamen University Affiliated Eye Center, 336 Xiahe Road, Xiamen, Fujian 361001, P.R. China, E-mail: <email>wubasel@hotmail.com</email></corresp><fn id="fn1-mmr-12-05-6577">
<label>&#x0002A;</label>
<p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="ppub">
<month>11</month>
<year>2015</year></pub-date>
<pub-date pub-type="epub">
<day>03</day>
<month>09</month>
<year>2015</year></pub-date>
<volume>12</volume>
<issue>5</issue>
<fpage>6577</fpage>
<lpage>6583</lpage>
<history>
<date date-type="received">
<day>05</day>
<month>09</month>
<year>2014</year></date>
<date date-type="accepted">
<day>27</day>
<month>05</month>
<year>2015</year></date></history>
<permissions>
<copyright-statement>Copyright: &#x000A9; Hu et al.</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions>
<abstract>
<p>The aim of the present study was to investigate the expression of leukemia inhibitory factor (LIF) and its downstream signaling pathways in the rat retina following acute ocular hypertension. The intraocular pressure of the rats was elevated to 110 mmHg for 1 h by infusing the anterior chamber with normal saline. The retinal tissues were obtained 12 h, 24 h, and 2, 3 and 7 days after termination of the ocular hypertension. Hematoxylin and eosin and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining were performed to assess the morphological changes and the apoptosis of retinal cells, respectively. Quantification of the retinal ganglion cells (RGCs) was performed using fluorogold retrograde (FG) staining. The expression levels of LIF, LIF receptor (LIFR), signal transducers and activators of transcription 3 (STAT3), phosphorylated STAT3 (P-STAT3), Akt, phosphorylated-Akt (P-Akt), extracellular signal-regulated kinase (ERK) and phosphorylated ERK (P-ERK) were determined at different time-points following acute ocular hypertension using western blot analysis. Reverse transcription-quantitative polymerase chain reaction was performned to detect the mRNA expression levels of LIF and LIFR. The results revealed that 12 h, 24 h, 2, 3 and 7 days after reperfusion, the thickness of the inner nuclear layer and the inner plexiform layer was decreased, with a significant reduction in the number of RGCs, as determined using TUNEL and FG staining. The expression levels of LIF and LIFR were increased following acute ocular hypertension. At 12 h post-retinal reperfusion, the expression levels of P-STAT3 and P-Akt were significantly upregulated, while the expression of P-ERK was decreased. The changes in the expression levels of LIF and LIFR suggested that LIF may be important in the process of degeneration/protection following retinal ischemia induced by acute ocular hypertension, via activation of the Janus kinase/STAT and Akt signaling pathways.</p></abstract>
<kwd-group>
<kwd>leukemia inhibitory factor</kwd>
<kwd>leukemia inhibitory factor receptor</kwd>
<kwd>Janus kinase-signal transducers and activators of transcription</kwd>
<kwd>Akt</kwd>
<kwd>acute ocular hypertension</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Glaucoma remains the leading cause of irreversible blindness globally, and the apoptosis and/or death of retinal ganglion cells (RGCs) induced by abnormally high intraocular pressure (IOP) is the predominant pathophysiological basis of glaucoma (<xref rid="b1-mmr-12-05-6577" ref-type="bibr">1</xref>). Lowering the elevated IOP in the eyes is the only effective treatment for glaucoma at present, however, a substantial proportion of patients with glaucoma experience visual field deterioration even following a significant IOP reduction, indicating progression of the disease (<xref rid="b2-mmr-12-05-6577" ref-type="bibr">2</xref>). Neuroprotection aiming to rescue RGCs from degeneration is, therefore, considered to be important in glaucoma treatment in addition to IOP reduction.</p>
<p>Leukemia inhibitory factor (LIF), a member of the interleukin (IL)-6 family, has been revealed to be a potential neuroprotective cytokine (<xref rid="b3-mmr-12-05-6577" ref-type="bibr">3</xref>). Members of the IL-6 family do not share sequence homology, however, they are able to activate the same receptor, glycoprotein 130 (gp130) (<xref rid="b4-mmr-12-05-6577" ref-type="bibr">4</xref>). Binding of LIF to its low-affinity LIF receptor (LIFR), results in the tyrosine phosphorylation of LIF, followed by the formation of a heterodimer. The heterodimer binds to its high-affinity receptor gp130 and exerts a variety of physiological effects via the activation of certain signaling pathways, including the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway and mitogen-activated protein kinase (MAPK) pathways, including the extracellular signal-regulated kinase (ERK) and/or phosphatidylinositol-3 kinase (PI3K) pathways (<xref rid="b5-mmr-12-05-6577" ref-type="bibr">5</xref>,<xref rid="b6-mmr-12-05-6577" ref-type="bibr">6</xref>).</p>
<p>LIF has been reported to prevent the death of axotomized sensory neurons in the dorsal root ganglia and promote peripheral regeneration in rats (<xref rid="b7-mmr-12-05-6577" ref-type="bibr">7</xref>,<xref rid="b8-mmr-12-05-6577" ref-type="bibr">8</xref>). A previous study also demonstrated that endogenous LIF has an axon protective capacity in acute experimental autoimmune encephalomyelitis in mice (<xref rid="b9-mmr-12-05-6577" ref-type="bibr">9</xref>).</p>
<p>In the eye, LIF protects photoreceptor cells against degeneration and extends the lifespan of photoreceptors following light-induced retinal damage (<xref rid="b10-mmr-12-05-6577" ref-type="bibr">10</xref>,<xref rid="b11-mmr-12-05-6577" ref-type="bibr">11</xref>). LIF is also reported to promote the <italic>in vitro</italic> generation, survival and maturation of oligodendrocytes of the rat optic nerve (<xref rid="b12-mmr-12-05-6577" ref-type="bibr">12</xref>). Furthermore, in a rat glaucoma model, upregulation in the gene expression of LIF is detected in early optic nerve head injury (<xref rid="b13-mmr-12-05-6577" ref-type="bibr">13</xref>), suggesting its potential role in the pathophysiology of glaucoma. However, the potential neuroprotective effect of LIF on RGCs in glaucoma remains to be fully elucidated. In the present study, the expression levels of LIF, LIFR and the downstream signaling pathway of LIF (STAT3, Akt and ERK1/2) were investigated in the rat retina following acute IOP elevation.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<sec>
<title>Establishment of a rat acute ocular hypertension model</title>
<p>All experimental procedures were performed in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and the experimental protocol was approved by the experimental animal ethics committee of Xiamen University (Xiamen, China). A total of 60 Sprague-Dawley rats (200&#x02013;250 g) were purchased from the Shanghai Laboratory Animal Center (Shanghai, China). The rats were maintained on a 12-h light-dark cycle and were dark-adapted for at least 2 h prior to experiments. The animals had <italic>ad libitum</italic> access to food (standard lab chow) and water. The rats were injected intraperitoneally with chloral hydrate (10 mg/100 g; Sinopharm Chemical Reagent Co., Ltd., Shanghai, China) to ensure the animals remained immobile. Pupil dilatation was achieved using 0.5% tropicamide (Alcon, Fort Worth, TX, USA). Following topical administration of 0.5% proparacaine (Alcon), the anterior chamber was cannulated with a 7-scalp acupuncture, which was connected to a container carrying 500 ml sterile normal saline. The IOP was increased to 110 mmHg by elevating the saline reservoir to 150 cm above the eye for 60 min. The body temperature of the rat was maintained at 37&#x000B0;C with a blanket. The opposite eye of each animal served as the normal control. The animals were sacrificed intraperitoneally with chloral hydrate (20 mg/100 g) 12 h, 24 h, 2, 3 or 7 days (n=10/group) following termination of the increase in IOP.</p></sec>
<sec>
<title>In situ staining of apoptotic cells</title>
<p>The rats (n=3/group) were anesthetized with an intraperitoneal injection of chloral hydrate (10 mg/100 g) and perfused intracardially with cold 4% paraformaldehyde (Sinopharm Chemical Reagent Co., Ltd.) in 0.1 mol/l phosphate-buffered saline (PBS; pH 7.4). The eyes were immediately enucleated and the globes were postfixed in 4% paraformaldehyde in 0.1 mol/l PBS for 2 h at 4&#x000B0;C. The cornea and the lens of the eye were removed, and the remaining eye cups were placed in the same fixative overnight. Prior to embedding in paraffin (Beijing Solarbio Science &amp; Technology Co., Ltd., Beijing, China), the eye cups were immersed in 70%, 95% and 100% ethyl alcohol in series, and then embedded with paraffin. Paraffin sections of 5-<italic>&#x000B5;</italic>m thickness were then cut with a semi-motorized rotary microtome (RM2245; Leica, Germany). To assess the end-stage apoptosis of the tissue, <italic>in situ</italic> terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was performed on the retinal tissues using an assay kit (DeadEnd Fluorometric TUNEL system G3250; Promega Corporation, Madison, WI, USA), according to the manufacturer's instructions. The cellular nuclei were stained with DAPI (Vector Laboratories, Inc., Burlingame, CA, USA), and the apoptotic cells were examined under a laser confocal microscope (Fluoview 1000; Olympus, Tokyo, Japan). The cellular nuclei and apoptotic cells were counted in three sections from each sample. As a positive control, sections were incubated in DNase I (0.5 <italic>&#x000B5;</italic>g/ml) prior to addition of the equilibration buffer. As a negative control, distilled water was used instead of the TdT reaction mixture.</p></sec>
<sec>
<title>Quantification of RGCs in rat retinal flat mounts</title>
<p>Retrograde staining of the RGCs of the two eyes was achieved by injecting a fluorescent dye into the superior colliculus bilaterally. The rats (n=3/group) were placed in a stereotactic apparatus (RWD Life Science Co. Ltd., Shenzhen, China), following intraperitoneal injection of 10 mg/100 g chloral hydrate to ensure the animals remained immobile and the skin of the skull was incised. The brain surface was exposed by perforating the parietal bone with a dental drill to facilitate dye injection. Fluorogold (FG; Fluorochrome LLC, Denver, CO, USA) was injected (4%; 3.0 <italic>&#x000B5;</italic>l each) at a point 5.00 mm caudal to the bregma and 1.00 mm lateral to the midline on the two sides, to a depth of 5.00 mm from the surface of the skull.</p>
<p>Subsequently, 10 days after the injection of FG into the superior colliculus, the eyes were enucleated following sacrifice of the animals with an overdose of intraperitoneal 10% chloral hydrate. The eyes were fixed in 4% paraformaldehyde in PBS for 1 h in the dark at 4&#x000B0;C. The anterior segments were removed and the eye cups were fixed in 4% paraformaldehyde/PBS for 30 min in the same conditions. A total of four radial cuts were made in the periphery of the eye cup, and the retina was carefully separated from the retinal pigment epithelium. A small cut was also made in the peripheral corner of the superior retinal portion in order to correctly identify retinal orientation.</p>
<p>The retina were then flat mounted on a glass slide and preserved in the dark at 4&#x000B0;C. The retinal flat mounts were viewed using a fluorescence microscope (Leica DM2500; Leica Microsystems GmbH, Wetzlar, Germany; magnification, &#x000D7;100). The FG-labeled RGCs were manually counted in a blinded-manner, by another investigator, in each quadrant at a distance of 1 mm radial from the optic nerve. The total quantity of RGCs per mm<sup>2</sup> in all four quadrants were calculated. Cells with an irregular shape, intense dye staining, or a smaller or larger size than typical RGCs were considered to be non-RGC cells, including microglia.</p></sec>
<sec>
<title>RNA extraction and reverse transcription-quantitative polymerase chain reaction (RT-qPCR)</title>
<p>Total RNA was extracted from the retina using TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA, USA). Reverse transcription was performed using Oligo 18T primers and RT reagents (Takara Bio Inc., Shiga, Japan), according to the manufacturer's instructions. RT-qPCR was performed with mRNA-specific primers. The following primer sequences were used: LIF, forward 5&#x02032;-<italic>tcaactggctcaactcaacg</italic>-3&#x02032; and reverse 5&#x02032;-<italic>aaaggtgggaaatccgtcat</italic>-3&#x02032;; and LIFR, forward 5&#x02032;-<italic>gctgacttctcgacctccac</italic>-3&#x02032; and reverse 5&#x02032;-<italic>ccagttccagtggtgacctt</italic>-3&#x02032;. The qPCR reactions were performed on the StepOne Plus real-time PCR system (Applied Biosystems, Foster City, CA, USA) with SYBR Premix Ex Taq (Takara Bio Inc.) at 95&#x000B0;C for 10 min, followed by 40 cycles of 95&#x000B0;C for 10 sec, 57&#x000B0;C for 30 sec and 75&#x000B0;C for 10 sec. Melt curve analysis was performed immediately between 65&#x000B0;C and 95&#x000B0;C. All reactions were performed in triplicate and average threshold cycle (Ct) values &gt;35 were considered to be negative.</p></sec>
<sec>
<title>Western blot analysis</title>
<p>The total protein from the retina at different time-points was extracted using cold radioimmunoprecipitation assay buffer (Beijing Solarbio Science &amp; Technology Co., Ltd.). The protein concentration was determined with a bicinchoninic acid protein assay (Pierce Biotechnology, Inc., Rockford, IL, USA). Equal quantities (3 mg/ml; 10 <italic>&#x000B5;</italic>l) of proteins extracted from the lysates were subjected to electrophoresis on 8% or 9% SDS-PAGE and then electrophoretically transferred onto polyvinylidene difluoride membranes (EMD Millipore, Billerica, MA, USA). Following blocking for 1 h in 2% bovine serum albumin, the membranes were incubated with primary antibodies against LIF (1:200; rabbit polyclonal anti-rat; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), LIFR (1:200; rabbit polyclonal anti-rat; Santa Cruz Biotechnology, Inc.), STAT3 (1:200, rabbit polyclonal anti-rat; Santa Cruz Biotechnology, Inc.), P-STAT3 (1:200; rabbit polyclonal anti-rat; Santa Cruz Biotechnology, Inc.), AKT (1:2,000; rabbit polyclonal anti-rat; Cell Signaling Technology, Danvers, MA, USA), p-AKT (1:1,000; rabbit polyclonal anti-rat; Cell Signaling Technology), ERK (1:1,000; rabbit polyclonal anti-rat; Cell Signaling Technology), p-ERK (1;1,000; rabbit polyclonal anti-rat; Cell Signaling Technology) and &#x003B2;-actin (1:10,000; Sigma-Aldrich, St. Louis, MO, USA) overnight at 4&#x000B0;C. Following three washes with Tris-buffered saline containing 0.05% Tween-20 for 10 min each, the membranes were incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG (1:10,000; Bio-Rad Laboratories, Inc., Hercules, CA, USA) for 1 h at room temperature. The specific bands were visualized using enhanced chemiluminescence reagents (Lulong Inc., Xiamen, China) and recorded using a transilluminator (ChemiDoc XRS, Bio-Rad Laboratories, Inc.). The data were analyzed using Image J software (National Institutes of Health, Bethesda, MD, USA). All experiments were performed at least three times with similar results.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>All data are expressed as the mean &#x000B1; standard error of the mean and were analyzed using one-way analysis of variance followed by Tukey's multiple comparison test with SPSS version 13.0 software (SPSS, Inc., Chicago, IL, USA). P&lt;0.05 was considered to indicate a statistically significant difference.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Retinal damage is induced by acute ocular hypertension</title>
<p>To assess the changes in retinal histopathology following acute ocular hypertension, hematoxylin and eosin staining was performed on the tissues. At 12 h, 24 h, 2, 3 and 7 days post-reperfusion, the thickness of the inner nuclear layer (INL) and the inner plexiform layer (IPL) gradually decreased, compared with the normal retina. The cell arrangement of the RGCs and the INL was irregular, with a significant reduction in the number of RGCs (<xref rid="f1-mmr-12-05-6577" ref-type="fig">Fig. 1</xref>). At 7 days post-reperfusion, cytoplasmic vacuolation occurred in the RGCs and cells were absent in the IPL (<xref rid="f1-mmr-12-05-6577" ref-type="fig">Fig. 1</xref>).</p></sec>
<sec>
<title>Apoptosis of the retinal cells is induced by acute ocular hypertension</title>
<p>TUNEL staining of normal retinas and retinas at 12 h, 24 h, 2, 3 or 7 days post-reperfusion after 60 min acute ocular hypertension is shown in <xref rid="f2-mmr-12-05-6577" ref-type="fig">Fig. 2</xref>. TUNEL-positive cells were absent in the normal retina (<xref rid="f2-mmr-12-05-6577" ref-type="fig">Fig. 2A</xref>), but were observed in the outer nuclear layer (ONL) and the INL in the group subjected to acute ocular hypertension at 12 h post-reperfusion (<xref rid="f2-mmr-12-05-6577" ref-type="fig">Fig. 2B&#x02013;F</xref>), and the number of apoptotic cells peaked 24 h after reperfusion.</p></sec>
<sec>
<title>RGC loss occurs following acute ocular hypertension</title>
<p>The results of the FG retrograde staining of RGCs are shown in <xref rid="f3-mmr-12-05-6577" ref-type="fig">Fig. 3</xref>. Following acute ocular hypertension, significant reductions in the numbers of RGCs were found at 24 h, 2, 3 and 7 days post-retinal reperfusion.</p></sec>
<sec>
<title>Expression levels of LIF and LIFR in the rat retina following acute ocular hypertension</title>
<p>Western blot analysis was performed to assess the protein levels of LIF and LIFR, and RT-qPCR was performed to determine the mRNA expression levels of LIF and LIFR following acute ocular hypertension in the rat retina (<xref rid="f4-mmr-12-05-6577" ref-type="fig">Fig. 4</xref>). The western blot analysis demonstrated that the protein expression of LIF was significantly increased at 12 h, 24 h, 2, 3 and 7 days, and peaked 12 h after the IOP increase was terminated (<xref rid="f4-mmr-12-05-6577" ref-type="fig">Fig. 4A and B</xref>). The protein level of LIFR was also significantly higher, compared with the normal control at 12 h post-retinal reperfusion, and peaking 3 days after reperfusion (<xref rid="f4-mmr-12-05-6577" ref-type="fig">Fig. 4C and D</xref>). The mRNA expression levels of LIF and LIFR revealed the same patterns as the protein expression of LIF and LIFR in the rat retina following acute ocular hypertension (<xref rid="f4-mmr-12-05-6577" ref-type="fig">Fig. 4E and F</xref>).</p></sec>
<sec>
<title>Assessment of the activation of STAT3, Akt and ERK in the rat retina</title>
<p>Activation of the downstream pathways of LIF were assessed by investigating the expression levels of the phosphorylated forms of STAT3, Akt and ERK (<xref rid="f5-mmr-12-05-6577" ref-type="fig">Fig. 5</xref>). The results revealed that, at 12 h post-retinal reperfusion, the levels of P-STAT3 were significantly higher than that in the normal retina, and the highest levels of P-STAT3 were observed 24 h after retinal reperfusion (<xref rid="f5-mmr-12-05-6577" ref-type="fig">Fig. 5A and B</xref>). Upregulation in the phosphorylation of Akt was also observed, which peaked 12 h after retinal reperfusion (<xref rid="f5-mmr-12-05-6577" ref-type="fig">Fig. 5A and C</xref>). In contrast to P-STAT3 and P-Akt, the level of P-ERK1/2 was reduced from 12 h after retinal reperfusion in the rat retina (<xref rid="f5-mmr-12-05-6577" ref-type="fig">Fig. 5A and D</xref>).</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Glaucoma is a group of neurodegenerative diseases characterized by structural damage to the optic nerve and visual field loss, which are induced by pathologically raised IOP, resulting in the death of RGCs. In previous decades, efforts have been made to establish a stable and replicable animal model of glaucoma to investigate the pathology and treatment of the damaged nerve. By cannulating the anterior chamber with a needle connected to a reservoir containing sterile saline, the IOP of an animal can be raised to an abnormally high level and can be higher than the ocular perfusion pressure, preventing ocular blood flow and causing retinal ischemia, resulting in the death of RGCs. The apoptosis of RGCs induced by acute ocular hypertension is considered to simulate, at least partially, the pathophysiology of acute angle-closure glaucoma (<xref rid="b14-mmr-12-05-6577" ref-type="bibr">14</xref>). In the present study, the results revealed thinning of the rat retina following acute ocular hypertension, particularly in the layers of the IPL, INL and RGCs. TUNEL-positive cell staining in the INL and ONL suggested the existence of cell apoptosis in the retina.</p>
<p>LIF is a multifunctional, pleiotropic cytokine (<xref rid="b15-mmr-12-05-6577" ref-type="bibr">15</xref>) with a wide variety of physiological functions in the body, promoting the proliferation of primordial germ cells and spermatocyte differentiation (<xref rid="b16-mmr-12-05-6577" ref-type="bibr">16</xref>,<xref rid="b17-mmr-12-05-6577" ref-type="bibr">17</xref>), inhibiting the differentiation of embryonic stem cells (<xref rid="b18-mmr-12-05-6577" ref-type="bibr">18</xref>,<xref rid="b19-mmr-12-05-6577" ref-type="bibr">19</xref>) and being involved in bone formation (<xref rid="b20-mmr-12-05-6577" ref-type="bibr">20</xref>,<xref rid="b21-mmr-12-05-6577" ref-type="bibr">21</xref>). Furthermore, as a neurotrophic factor, LIF is reported to enhance the regeneration of axotomized sciatic nerves, accelerating the repair of the injured sensory nerve, promoting olfactory sensory neuron regeneration and corneal nerve recovery following laser <italic>in situ</italic> keratomileusis (<xref rid="b22-mmr-12-05-6577" ref-type="bibr">22</xref>&#x02013;<xref rid="b25-mmr-12-05-6577" ref-type="bibr">25</xref>).</p>
<p>In the retina, LIF is produced predominantly in the M&#x000FC;ller cells. Previous reports have demonstrated that the expression of LIF is markedly upregulated in the mouse retina when light damage is induced with bright cyclic light preconditioning (<xref rid="b26-mmr-12-05-6577" ref-type="bibr">26</xref>,<xref rid="b27-mmr-12-05-6577" ref-type="bibr">27</xref>). The present study demonstrated that the number of apoptotic cells increased significantly 12 h after acute ocular hypertension and peaked at 24, followed by a decrease. The apoptotic cells were located predominantly in the INL 12 h and 24 h after termination of ocular hypertension, while from day 2, the apoptotic cells were scattered in the ONL (<xref rid="f2-mmr-12-05-6577" ref-type="fig">Fig. 2</xref>). A significant reduction in the number of RGCs was noted at 24 h after acute ocular hypertension. The protein and mRNA expression levels of LIF were upregulated following acute ocular hypertension, peaking at 12 h. The expression pattern of LIF was consistent with the change in the number of apoptotic cells in the retina (<xref rid="f4-mmr-12-05-6577" ref-type="fig">Fig. 4</xref>). The expression of LIFR was increased steadily following acute ocular hypertension-induced ischemia and peaked after 3 days. An explanation for this inconsistency in the expression of LIFR and LIF was that the LIFR is able to bind with several cytokines in addition to LIF, including ciliary neurotrophic factor (CNTF), cardiotrophin-1 and oncostatin M, which, in turn alter the expression of LIFR (<xref rid="b28-mmr-12-05-6577" ref-type="bibr">28</xref>&#x02013;<xref rid="b31-mmr-12-05-6577" ref-type="bibr">31</xref>). Notably, the expression of CNTF has been reported to increase following acute ocular hypertension in the rat retina (<xref rid="b32-mmr-12-05-6577" ref-type="bibr">32</xref>).</p>
<p>It has been reported that LIF is involved in the protection of photoreceptors against light-induced injury, predominantly through activation of the JAK-STAT3 pathway (<xref rid="b10-mmr-12-05-6577" ref-type="bibr">10</xref>,<xref rid="b11-mmr-12-05-6577" ref-type="bibr">11</xref>). In the present study, the results of the western blot analysis demonstrated increased expression of P-STAT3 in the retina following acute ocular hypertension. In addition, the Akt pathway has been reported to have potent effects on neuroprotection in the retina. When phosphorylated, the Akt kinase promotes cell survival via the inactivation of apoptosis-associated components in the cell. Inactivation of the Akt signaling pathway is considered to be responsible for photoreceptor apoptosis in the mouse model of retinal degeneration (<xref rid="b33-mmr-12-05-6577" ref-type="bibr">33</xref>). LIF has been reported to activate the PI3K signaling pathways, including Akt in cardiac myocytes (<xref rid="b3-mmr-12-05-6577" ref-type="bibr">3</xref>,<xref rid="b6-mmr-12-05-6577" ref-type="bibr">6</xref>,<xref rid="b34-mmr-12-05-6577" ref-type="bibr">34</xref>,<xref rid="b35-mmr-12-05-6577" ref-type="bibr">35</xref>). In the present study, the increase in the expression of LIF was associated with elevated P-Akt levels in the retina following retinal ischemia induced by acute ocular hypertension. These results suggested that LIF may mediate the processes of injury and repair in the retina through activation of the JAK-STAT3 and Akt signaling pathways.</p>
<p>As an MAPK pathway, the ERK pathway has been reported to be involved in cell proliferation and differentiation (<xref rid="b36-mmr-12-05-6577" ref-type="bibr">36</xref>) when activated by mitogenic stimuli, including growth factors, cytokines, and phorbol esters. It has been reported that ERK activation is necessary for synaptic plasticity and memory in the central nervous system (<xref rid="b37-mmr-12-05-6577" ref-type="bibr">37</xref>). In the rat retina, Roth <italic>et al</italic> (<xref rid="b38-mmr-12-05-6577" ref-type="bibr">38</xref>) revealed that the expression of P-ERK peaked between 1 and 6 h following ischemia, followed by a decrease. Only weak expression levels of P-ERK were detected between days 3 and 7. The number of apoptotic cells in the RGC and photoreceptor layers are markedly decreased following the inhibition of ERK activation (<xref rid="b38-mmr-12-05-6577" ref-type="bibr">38</xref>). In the present study, significant downregulation of the expression of P-ERK was observed in the rat retina following an acute increase in IOP. These observations were consistent with the findings of Roth <italic>et al</italic> (<xref rid="b38-mmr-12-05-6577" ref-type="bibr">38</xref>), described above. Namura <italic>et al</italic> also demonstrated that intravenous injection of the MAPK/ERK kinase inhibitor, U0126, protects brain tissues from damage following forebrain and focal cerebral ischemia (<xref rid="b39-mmr-12-05-6577" ref-type="bibr">39</xref>). However, the mechanisms responsible for cell death following ERK activation require further investigation.</p>
<p>In conclusion, the dynamic changes in the expression levels of LIF and LIFR observed in the present study suggested that LIF may be important in the process of degeneration/protection following acute ocular hypertension-induced retinal ischemia via the JAK-STAT3 and Akt signaling pathways.</p></sec></body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors would like to thank Dr Zhen Zhang and Dr Yanfeng Chen for their assistance in animal experiments. This study was supported by the National Natural Science Foundation of China (grant no. 81170841) and Xiamen Science and Technology Project (grant nos. 3502Z20116011 and 3502Z20134040).</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-mmr-12-05-6577"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>JZ</given-names></name><name><surname>Elyaman</surname><given-names>W</given-names></name><name><surname>Yip</surname><given-names>HK</given-names></name><name><surname>Lee</surname><given-names>VW</given-names></name><name><surname>Yick</surname><given-names>LW</given-names></name><name><surname>Hugon</surname><given-names>J</given-names></name></person-group><article-title>The possible involvement of STAT3 pathway</article-title><source>Eur J nerurosci</source><volume>19</volume><fpage>265</fpage><lpage>272</lpage><year>2004</year><pub-id pub-id-type="doi">10.1111/j.0953-816X.2003.03107.x</pub-id></element-citation></ref>
<ref id="b2-mmr-12-05-6577"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciotu</surname><given-names>IM</given-names></name><name><surname>Stoian</surname><given-names>I</given-names></name><name><surname>Gaman</surname><given-names>L</given-names></name><name><surname>Popescu</surname><given-names>MV</given-names></name><name><surname>Atanasiu</surname><given-names>V</given-names></name></person-group><article-title>Biochemical changes and treatment in glaucoma</article-title><source>J Med Life</source><volume>8</volume><fpage>28</fpage><lpage>31</lpage><year>2015</year><pub-id pub-id-type="pmid">25914734</pub-id><pub-id pub-id-type="pmcid">4397515</pub-id></element-citation></ref>
<ref id="b3-mmr-12-05-6577"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinrich</surname><given-names>PC</given-names></name><name><surname>Behrmann</surname><given-names>I</given-names></name><name><surname>Haan</surname><given-names>S</given-names></name><name><surname>Hermanns</surname><given-names>HM</given-names></name><name><surname>M&#x000FC;ller-Newen</surname><given-names>G</given-names></name><name><surname>Schaper</surname><given-names>F</given-names></name></person-group><article-title>Principles of interleukin (IL)-6-type cytokine signalling and its regulation</article-title><source>Biochem J</source><volume>374</volume><fpage>1</fpage><lpage>20</lpage><year>2003</year><pub-id pub-id-type="doi">10.1042/bj20030407</pub-id><pub-id pub-id-type="pmid">12773095</pub-id><pub-id pub-id-type="pmcid">1223585</pub-id></element-citation></ref>
<ref id="b4-mmr-12-05-6577"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamauchi-Takihara</surname><given-names>K</given-names></name></person-group><article-title>Gp130-mediated pathway and let ventricular remodeling</article-title><source>J Card Fail</source><volume>8</volume><issue>6 Suppl</issue><fpage>S374</fpage><lpage>S378</lpage><year>2002</year><pub-id pub-id-type="doi">10.1054/jcaf.2002.129254</pub-id></element-citation></ref>
<ref id="b5-mmr-12-05-6577"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auernhammer</surname><given-names>CJ</given-names></name><name><surname>Melmed</surname><given-names>S</given-names></name></person-group><article-title>Leukemia-inhibitory factor-neuroimmnue modulator of endocrine function</article-title><source>Endocr Rev</source><volume>21</volume><fpage>313</fpage><lpage>345</lpage><year>2000</year><pub-id pub-id-type="pmid">10857556</pub-id></element-citation></ref>
<ref id="b6-mmr-12-05-6577"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>H</given-names></name><name><surname>Fujio</surname><given-names>Y</given-names></name><name><surname>kunisada</surname><given-names>K</given-names></name><name><surname>Hirota</surname><given-names>H</given-names></name><name><surname>Matsui</surname><given-names>H</given-names></name><name><surname>Kishimoto</surname><given-names>T</given-names></name><name><surname>Yamauchi-Takihara</surname><given-names>K</given-names></name></person-group><article-title>Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 s6 kinase phosphorylation in cardiac myocytes</article-title><source>J Biol Chem</source><volume>273</volume><fpage>9703</fpage><lpage>9710</lpage><year>1998</year><pub-id pub-id-type="doi">10.1074/jbc.273.16.9703</pub-id><pub-id pub-id-type="pmid">9545305</pub-id></element-citation></ref>
<ref id="b7-mmr-12-05-6577"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheema</surname><given-names>SS</given-names></name><name><surname>Richards</surname><given-names>L</given-names></name><name><surname>Murphy</surname><given-names>M</given-names></name><name><surname>Bartlett</surname><given-names>PF</given-names></name></person-group><article-title>Leukemia inhibitory factor prevents the death of axotomised sensory neurons in the dorsal root ganglia of the neonatal rat</article-title><source>J Neurosci Res</source><volume>37</volume><fpage>213</fpage><lpage>218</lpage><year>1994</year><pub-id pub-id-type="doi">10.1002/jnr.490370207</pub-id><pub-id pub-id-type="pmid">8151729</pub-id></element-citation></ref>
<ref id="b8-mmr-12-05-6577"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mckay Hart</surname><given-names>A</given-names></name><name><surname>Wiberg</surname><given-names>M</given-names></name><name><surname>Terenghi</surname><given-names>G</given-names></name></person-group><article-title>Exogenous leukemia inhibitory factor enhances nerve regeneration after late secondary repair using a bioartificial nerve conduit</article-title><source>Br J plast surg</source><volume>56</volume><fpage>444</fpage><lpage>450</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/S0007-1226(03)00134-6</pub-id><pub-id pub-id-type="pmid">12890457</pub-id></element-citation></ref>
<ref id="b9-mmr-12-05-6577"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gresle</surname><given-names>MM</given-names></name><name><surname>Alexandrou</surname><given-names>E</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Egan</surname><given-names>G</given-names></name><name><surname>Jokubaitis</surname><given-names>V</given-names></name><name><surname>Ayers</surname><given-names>M</given-names></name><name><surname>Jonas</surname><given-names>A</given-names></name><name><surname>Doherty</surname><given-names>W</given-names></name><name><surname>Friedhuber</surname><given-names>A</given-names></name><name><surname>Shaw</surname><given-names>G</given-names></name><etal/></person-group><article-title>Leukemia inhibitory factor protects axons in experimental autoimmune encephalomyelitis via an oligodendrocyte-independent mechanism</article-title><source>PLoS One</source><volume>7</volume><fpage>e47379</fpage><year>2012</year><pub-id pub-id-type="doi">10.1371/journal.pone.0047379</pub-id><pub-id pub-id-type="pmid">23077604</pub-id><pub-id pub-id-type="pmcid">3471848</pub-id></element-citation></ref>
<ref id="b10-mmr-12-05-6577"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000FC;rgi</surname><given-names>S</given-names></name><name><surname>Samardziia</surname><given-names>M</given-names></name><name><surname>Grimm</surname><given-names>C</given-names></name></person-group><article-title>Endogenous leukemia inhibitory factor protects photoreceptor cells against light-induced degeneration</article-title><source>Mol Vis</source><volume>15</volume><fpage>1631</fpage><lpage>1637</lpage><year>2009</year><pub-id pub-id-type="pmid">19693290</pub-id><pub-id pub-id-type="pmcid">2728564</pub-id></element-citation></ref>
<ref id="b11-mmr-12-05-6577"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joly</surname><given-names>S</given-names></name><name><surname>Lange</surname><given-names>C</given-names></name><name><surname>Thiersch</surname><given-names>M</given-names></name><name><surname>Samardzija</surname><given-names>M</given-names></name><name><surname>Grimm</surname><given-names>C</given-names></name></person-group><article-title>Leukemia inhibitory factor extends the lifespan of injured photo-receptors in vivo</article-title><source>J Neurosci</source><volume>28</volume><fpage>13765</fpage><lpage>13774</lpage><year>2008</year><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5114-08.2008</pub-id><pub-id pub-id-type="pmid">19091967</pub-id></element-citation></ref>
<ref id="b12-mmr-12-05-6577"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>M</given-names></name><name><surname>Bhakoo</surname><given-names>K</given-names></name><name><surname>Noble</surname><given-names>M</given-names></name></person-group><article-title>Ciliary nerrotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro</article-title><source>Development</source><volume>120</volume><fpage>143</fpage><lpage>153</lpage><year>1994</year><pub-id pub-id-type="pmid">8119123</pub-id></element-citation></ref>
<ref id="b13-mmr-12-05-6577"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>EC</given-names></name><name><surname>Doser</surname><given-names>TA</given-names></name><name><surname>Cepurna</surname><given-names>WO</given-names></name><name><surname>Dyck</surname><given-names>JA</given-names></name><name><surname>Jia</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Lambert</surname><given-names>WS</given-names></name><name><surname>Morrison</surname><given-names>JC</given-names></name></person-group><article-title>Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma</article-title><source>Invest Ophthalmol Vis Sci</source><volume>52</volume><fpage>504</fpage><lpage>518</lpage><year>2011</year><pub-id pub-id-type="doi">10.1167/iovs.10-5317</pub-id><pub-id pub-id-type="pmcid">3053294</pub-id></element-citation></ref>
<ref id="b14-mmr-12-05-6577"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>TV</given-names></name><name><surname>Tomarev</surname><given-names>SI</given-names></name></person-group><article-title>Rodent models of glaucoma</article-title><source>Brain Res Bull</source><volume>81</volume><fpage>349</fpage><lpage>358</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.brainresbull.2009.04.004</pub-id><pub-id pub-id-type="pmcid">2830899</pub-id></element-citation></ref>
<ref id="b15-mmr-12-05-6577"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metcalf</surname><given-names>D</given-names></name></person-group><article-title>The unsolved enigmas of leukemia inhibitory factor</article-title><source>Stem Cells</source><volume>21</volume><fpage>5</fpage><lpage>14</lpage><year>2003</year><pub-id pub-id-type="doi">10.1634/stemcells.21-1-5</pub-id><pub-id pub-id-type="pmid">12529546</pub-id></element-citation></ref>
<ref id="b16-mmr-12-05-6577"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piguet-Pellorce</surname><given-names>C</given-names></name><name><surname>Dorval-Coiffec</surname><given-names>I</given-names></name><name><surname>Pham</surname><given-names>MD</given-names></name><name><surname>J&#x000E9;gou</surname><given-names>B</given-names></name></person-group><article-title>Leukemia inhibitory factor expression and regulation within the testis</article-title><source>Endocrinonlogy</source><volume>141</volume><fpage>1136</fpage><lpage>1141</lpage><year>2000</year><pub-id pub-id-type="doi">10.1210/endo.141.3.7399</pub-id></element-citation></ref>
<ref id="b17-mmr-12-05-6577"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sariola</surname><given-names>H</given-names></name></person-group><article-title>The neurotrophic factors in non-neuronal tissues</article-title><source>Cell Mol Life Sci</source><volume>58</volume><fpage>1061</fpage><lpage>1066</lpage><year>2001</year><pub-id pub-id-type="doi">10.1007/PL00000921</pub-id><pub-id pub-id-type="pmid">11529499</pub-id></element-citation></ref>
<ref id="b18-mmr-12-05-6577"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>RL</given-names></name><name><surname>Hilton</surname><given-names>DJ</given-names></name><name><surname>Pease</surname><given-names>S</given-names></name><name><surname>Willson</surname><given-names>TA</given-names></name><name><surname>Stewart</surname><given-names>CL</given-names></name><name><surname>Gearing</surname><given-names>DP</given-names></name><name><surname>Wagner</surname><given-names>EF</given-names></name><name><surname>Metcalf</surname><given-names>D</given-names></name><name><surname>Nicola</surname><given-names>NA</given-names></name><name><surname>Gough</surname><given-names>NM</given-names></name></person-group><article-title>Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells</article-title><source>Nature</source><volume>336</volume><fpage>684</fpage><lpage>687</lpage><year>1988</year><pub-id pub-id-type="doi">10.1038/336684a0</pub-id><pub-id pub-id-type="pmid">3143916</pub-id></element-citation></ref>
<ref id="b19-mmr-12-05-6577"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>AG</given-names></name><name><surname>Health</surname><given-names>JK</given-names></name><name><surname>Donaldson</surname><given-names>DD</given-names></name><name><surname>Wong</surname><given-names>GG</given-names></name><name><surname>Moreau</surname><given-names>J</given-names></name><name><surname>Stahl</surname><given-names>M</given-names></name><name><surname>Rogers</surname><given-names>D</given-names></name></person-group><article-title>Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides</article-title><source>Nature</source><volume>336</volume><fpage>688</fpage><lpage>690</lpage><year>1988</year><pub-id pub-id-type="doi">10.1038/336688a0</pub-id><pub-id pub-id-type="pmid">3143917</pub-id></element-citation></ref>
<ref id="b20-mmr-12-05-6577"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>LR</given-names></name><name><surname>Lowe</surname><given-names>C</given-names></name><name><surname>Cornish</surname><given-names>J</given-names></name><name><surname>Skinner</surname><given-names>SJ</given-names></name><name><surname>Hilton</surname><given-names>DJ</given-names></name><name><surname>Willson</surname><given-names>TA</given-names></name><name><surname>Gearing</surname><given-names>DP</given-names></name><name><surname>Martin</surname><given-names>TJ</given-names></name></person-group><article-title>Leukemia inhibitory factor: A novel bone-active cytokine</article-title><source>Endocrinology</source><volume>126</volume><fpage>1416</fpage><lpage>1420</lpage><year>1990</year><pub-id pub-id-type="doi">10.1210/endo-126-3-1416</pub-id><pub-id pub-id-type="pmid">2106430</pub-id></element-citation></ref>
<ref id="b21-mmr-12-05-6577"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dazai</surname><given-names>S</given-names></name><name><surname>Akita</surname><given-names>S</given-names></name><name><surname>Hirano</surname><given-names>A</given-names></name><name><surname>Rashid</surname><given-names>MA</given-names></name><name><surname>Naito</surname><given-names>S</given-names></name><name><surname>Akino</surname><given-names>K</given-names></name><name><surname>Fujii</surname><given-names>T</given-names></name></person-group><article-title>Leukemia inhibitory factor enhances bone formation in calvarial bone defect</article-title><source>J Craniofac Srug</source><volume>11</volume><fpage>513</fpage><lpage>520</lpage><year>2000</year><pub-id pub-id-type="doi">10.1097/00001665-200011060-00002</pub-id></element-citation></ref>
<ref id="b22-mmr-12-05-6577"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dowsing</surname><given-names>BJ</given-names></name><name><surname>Hayes</surname><given-names>A</given-names></name><name><surname>Bennett</surname><given-names>TM</given-names></name><name><surname>Morrison</surname><given-names>WA</given-names></name><name><surname>Messina</surname><given-names>A</given-names></name></person-group><article-title>Effects of LIF dose and laminin plus fibronectin on axotomized sciatic nerves</article-title><source>Muscle Nerve</source><volume>23</volume><fpage>1356</fpage><lpage>1364</lpage><year>2000</year><pub-id pub-id-type="doi">10.1002/1097-4598(200009)23:9&lt;1356::AID-MUS6&gt;3.0.CO;2-2</pub-id><pub-id pub-id-type="pmid">10951438</pub-id></element-citation></ref>
<ref id="b23-mmr-12-05-6577"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cafferty</surname><given-names>WB</given-names></name><name><surname>Gardiner</surname><given-names>NJ</given-names></name><name><surname>Gavazzi</surname><given-names>I</given-names></name><name><surname>Powell</surname><given-names>J</given-names></name><name><surname>McMahon</surname><given-names>SB</given-names></name><name><surname>Heath</surname><given-names>JK</given-names></name><name><surname>Munson</surname><given-names>J</given-names></name><name><surname>Cohen</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>SW</given-names></name></person-group><article-title>Leukemia inhibitory factor determines the growth status of injured adult sensory neurons</article-title><source>J Neurosci</source><volume>21</volume><fpage>7161</fpage><lpage>7170</lpage><year>2001</year><pub-id pub-id-type="pmid">11549727</pub-id></element-citation></ref>
<ref id="b24-mmr-12-05-6577"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>S</given-names></name><name><surname>Rasika</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Mauduit</surname><given-names>C</given-names></name><name><surname>Raccurt</surname><given-names>M</given-names></name><name><surname>Morel</surname><given-names>G</given-names></name><name><surname>Jourdan</surname><given-names>F</given-names></name><name><surname>Benahmed</surname><given-names>M</given-names></name><name><surname>Moyse</surname><given-names>E</given-names></name><name><surname>Patterson</surname><given-names>PH</given-names></name></person-group><article-title>Leukemia inhibitory factor is a key signal for injury-induced neurogenesis in the adult mouse olfactory epithelium</article-title><source>J Neurosci</source><volume>23</volume><fpage>1792</fpage><lpage>1803</lpage><year>2003</year><pub-id pub-id-type="pmid">12629183</pub-id></element-citation></ref>
<ref id="b25-mmr-12-05-6577"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name></person-group><article-title>Effect of leukemia inhibitory factor on corneal nerve regeneration of rabbit eyes after laser in situ keratomileusis</article-title><source>Neurosci Lett</source><volume>499</volume><fpage>99</fpage><lpage>103</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.neulet.2011.05.042</pub-id><pub-id pub-id-type="pmid">21640792</pub-id></element-citation></ref>
<ref id="b26-mmr-12-05-6577"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chollangi</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name><name><surname>Quinn</surname><given-names>J</given-names></name><name><surname>Ash</surname><given-names>JD</given-names></name></person-group><article-title>Preconditioning-induced protection from oxidative injury is mediated by leukemia inhibitory factor receptor (LIFR) and its ligands in the retina</article-title><source>Neurobiol Dis</source><volume>34</volume><fpage>535</fpage><lpage>544</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.nbd.2009.03.012</pub-id><pub-id pub-id-type="pmid">19344761</pub-id><pub-id pub-id-type="pmcid">2683190</pub-id></element-citation></ref>
<ref id="b27-mmr-12-05-6577"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueki</surname><given-names>Y</given-names></name><name><surname>Le</surname><given-names>YZ</given-names></name><name><surname>Chollangi</surname><given-names>S</given-names></name><name><surname>Muller</surname><given-names>W</given-names></name><name><surname>Ash</surname><given-names>JD</given-names></name></person-group><article-title>Preconditioning-induced protection of photoreceptors requires activation of the signal-transducing receptor gp130 in photoreceptors</article-title><source>Proc Natl Acad Sci USA</source><volume>106</volume><fpage>21389</fpage><lpage>21394</lpage><year>2009</year><pub-id pub-id-type="doi">10.1073/pnas.0906156106</pub-id><pub-id pub-id-type="pmid">19948961</pub-id><pub-id pub-id-type="pmcid">2785722</pub-id></element-citation></ref>
<ref id="b28-mmr-12-05-6577"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>S</given-names></name><name><surname>Aldrich</surname><given-names>TH</given-names></name><name><surname>Stahl</surname><given-names>N</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name><name><surname>Taga</surname><given-names>T</given-names></name><name><surname>Kishimoto</surname><given-names>T</given-names></name><name><surname>Ip</surname><given-names>NY</given-names></name><name><surname>Yancopoulos</surname><given-names>GD</given-names></name></person-group><article-title>LIRR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor</article-title><source>Science</source><volume>260</volume><fpage>1805</fpage><lpage>1808</lpage><year>1993</year><pub-id pub-id-type="doi">10.1126/science.8390097</pub-id><pub-id pub-id-type="pmid">8390097</pub-id></element-citation></ref>
<ref id="b29-mmr-12-05-6577"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennica</surname><given-names>D</given-names></name><name><surname>Shaw</surname><given-names>KJ</given-names></name><name><surname>Swanson</surname><given-names>TA</given-names></name><name><surname>Moore</surname><given-names>MW</given-names></name><name><surname>Shelton</surname><given-names>DL</given-names></name><name><surname>Zioncheck</surname><given-names>KA</given-names></name><name><surname>Rosenthal</surname><given-names>A</given-names></name><name><surname>Taga</surname><given-names>T</given-names></name><name><surname>Paoni</surname><given-names>NF</given-names></name><name><surname>Wood</surname><given-names>WI</given-names></name></person-group><article-title>Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex</article-title><source>J Biol Chem</source><volume>270</volume><fpage>10915</fpage><lpage>10922</lpage><year>1995</year><pub-id pub-id-type="pmid">7738033</pub-id></element-citation></ref>
<ref id="b30-mmr-12-05-6577"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gearing</surname><given-names>DP</given-names></name><name><surname>Bruce</surname><given-names>AG</given-names></name></person-group><article-title>Oncostatin M binds the high-affinity leukemia inhibitory factor receptor</article-title><source>New Biol</source><volume>4</volume><fpage>61</fpage><lpage>65</lpage><year>1992</year><pub-id pub-id-type="pmid">1536831</pub-id></element-citation></ref>
<ref id="b31-mmr-12-05-6577"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plun-Favreau</surname><given-names>H</given-names></name><name><surname>Perret</surname><given-names>D</given-names></name><name><surname>Diveu</surname><given-names>C</given-names></name><name><surname>Froger</surname><given-names>J</given-names></name><name><surname>Chevalier</surname><given-names>S</given-names></name><name><surname>Leli&#x000E8;vre</surname><given-names>E</given-names></name><name><surname>Gascan</surname><given-names>H</given-names></name><name><surname>Chabbert</surname><given-names>M</given-names></name></person-group><article-title>Leukemia inhibitory factor (LIF), cardiotrophin-1 and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor</article-title><source>J Biol Chem</source><volume>278</volume><fpage>27169</fpage><lpage>27179</lpage><year>2003</year><pub-id pub-id-type="doi">10.1074/jbc.M303168200</pub-id><pub-id pub-id-type="pmid">12707269</pub-id></element-citation></ref>
<ref id="b32-mmr-12-05-6577"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju</surname><given-names>WK</given-names></name><name><surname>Lee</surname><given-names>MY</given-names></name><name><surname>Hofmann</surname><given-names>HD</given-names></name><name><surname>Kirsch</surname><given-names>M</given-names></name><name><surname>Oh</surname><given-names>SJ</given-names></name><name><surname>Chung</surname><given-names>JW</given-names></name><name><surname>Chun</surname><given-names>MH</given-names></name></person-group><article-title>Increased expression of ciliary neurotrophic factor receptor alpha mRNA in the ischemic rat retina</article-title><source>Neurosci Lett</source><volume>283</volume><fpage>133</fpage><lpage>136</lpage><year>2000</year><pub-id pub-id-type="doi">10.1016/S0304-3940(00)00931-9</pub-id><pub-id pub-id-type="pmid">10739893</pub-id></element-citation></ref>
<ref id="b33-mmr-12-05-6577"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jomary</surname><given-names>C</given-names></name><name><surname>Cullen</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>SE</given-names></name></person-group><article-title>Inactivation of the Akt survival pathway during photoreceptor apoptosis in the retinal degeneration mouse</article-title><source>Invest Ophthalmol Vis Sci</source><volume>47</volume><fpage>1620</fpage><lpage>1629</lpage><year>2006</year><pub-id pub-id-type="doi">10.1167/iovs.05-1176</pub-id><pub-id pub-id-type="pmid">16565401</pub-id></element-citation></ref>
<ref id="b34-mmr-12-05-6577"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hideshima</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>N</given-names></name><name><surname>Chauhan</surname><given-names>D</given-names></name><name><surname>Anderson</surname><given-names>KC</given-names></name></person-group><article-title>Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma</article-title><source>Oncogene</source><volume>20</volume><fpage>5991</fpage><lpage>6000</lpage><year>2001</year><pub-id pub-id-type="doi">10.1038/sj.onc.1204833</pub-id><pub-id pub-id-type="pmid">11593406</pub-id></element-citation></ref>
<ref id="b35-mmr-12-05-6577"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jee</surname><given-names>SH</given-names></name><name><surname>Chiu</surname><given-names>HC</given-names></name><name><surname>Tsai</surname><given-names>TF</given-names></name><name><surname>Tsai</surname><given-names>WL</given-names></name><name><surname>Liao</surname><given-names>YH</given-names></name><name><surname>Chu</surname><given-names>CY</given-names></name><name><surname>Kuo</surname><given-names>ML</given-names></name></person-group><article-title>The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells</article-title><source>J Invest Dermatol</source><volume>119</volume><fpage>1121</fpage><lpage>1127</lpage><year>2002</year><pub-id pub-id-type="doi">10.1046/j.1523-1747.2002.19503.x</pub-id><pub-id pub-id-type="pmid">12445202</pub-id></element-citation></ref>
<ref id="b36-mmr-12-05-6577"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Fujii</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Roberts</surname><given-names>T</given-names></name><name><surname>Fu</surname><given-names>H</given-names></name></person-group><article-title>Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism</article-title><source>Proc Natl Acad Sci USA</source><volume>98</volume><fpage>7783</fpage><lpage>7788</lpage><year>2001</year><pub-id pub-id-type="doi">10.1073/pnas.141224398</pub-id><pub-id pub-id-type="pmid">11427728</pub-id><pub-id pub-id-type="pmcid">35419</pub-id></element-citation></ref>
<ref id="b37-mmr-12-05-6577"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweatt</surname><given-names>JD</given-names></name></person-group><article-title>The neuronal MAP kinase cascade: A biochemical signal integration system subserving synaptic plasticity and memory</article-title><source>J Neurochem</source><volume>76</volume><fpage>1</fpage><lpage>10</lpage><year>2001</year><pub-id pub-id-type="doi">10.1046/j.1471-4159.2001.00054.x</pub-id><pub-id pub-id-type="pmid">11145972</pub-id></element-citation></ref>
<ref id="b38-mmr-12-05-6577"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname><given-names>S</given-names></name><name><surname>Shaikh</surname><given-names>AR</given-names></name><name><surname>Hennelly</surname><given-names>MM</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Bindokas</surname><given-names>V</given-names></name><name><surname>Graham</surname><given-names>CE</given-names></name></person-group><article-title>Mitogen-activated protein kinases and retinal ischemia</article-title><source>Invest Ophthalmol Vis Sci</source><volume>44</volume><fpage>5383</fpage><lpage>5395</lpage><year>2003</year><pub-id pub-id-type="doi">10.1167/iovs.03-0451</pub-id><pub-id pub-id-type="pmid">14638742</pub-id></element-citation></ref>
<ref id="b39-mmr-12-05-6577"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namura</surname><given-names>S</given-names></name><name><surname>Iihara</surname><given-names>K</given-names></name><name><surname>Takami</surname><given-names>S</given-names></name><name><surname>Nagata</surname><given-names>I</given-names></name><name><surname>Kikuchi</surname><given-names>H</given-names></name><name><surname>Matsushita</surname><given-names>K</given-names></name><name><surname>Moskowitz</surname><given-names>MA</given-names></name><name><surname>Bonventre</surname><given-names>JV</given-names></name><name><surname>Alessandrini</surname><given-names>A</given-names></name></person-group><article-title>Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia</article-title><source>Proc Natl Acad Sci USA</source><volume>98</volume><fpage>11569</fpage><lpage>11574</lpage><year>2001</year><pub-id pub-id-type="doi">10.1073/pnas.181213498</pub-id><pub-id pub-id-type="pmid">11504919</pub-id><pub-id pub-id-type="pmcid">58770</pub-id></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-mmr-12-05-6577" position="float">
<label>Figure 1</label>
<caption>
<p>Hematoxylin and eosin staining of the rat retina following acute ocular hypertension for 1 h. (A) Normal control; (B) 12 h, (C) 24 h, (D) 2 days, (E) 3 days and (F) 7 days after acute ocular hypertension.</p></caption>
<graphic xlink:href="MMR-12-05-6577-g00.jpg"/></fig>
<fig id="f2-mmr-12-05-6577" position="float">
<label>Figure 2</label>
<caption>
<p>TUNEL staining of rat retinal cells following acute ocular hypertension. (A) Normal control; (B) 12 h, (C) 24 h, (D) 2 days, (E) 3 days and (F) 7 days after acute ocular hypertension. No TUNEL-positive cells were observed in the normal control, however, (B&#x02013;F) TUNEL-positive cells were present in the ONL and INL of the retina 12 h after acute ocular hypertension. Green indicates TUNEL-positive staining and blue indicates DAPI nuclear staining. ONL: outer nuclear layer; INL: inner nuclear layer; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling.</p></caption>
<graphic xlink:href="MMR-12-05-6577-g01.jpg"/></fig>
<fig id="f3-mmr-12-05-6577" position="float">
<label>Figure 3</label>
<caption>
<p>Fluorogold retrograde staining of retinal ganglion cells in the rat retina following acute ocular hypertension. Data are expressed as the mean &#x000B1; standard error of the mean. <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01, <sup>&#x0002A;&#x0002A;&#x0002A;</sup>P&lt;0.001, vs. normal. N, normal control.</p></caption>
<graphic xlink:href="MMR-12-05-6577-g02.tif"/></fig>
<fig id="f4-mmr-12-05-6577" position="float">
<label>Figure 4</label>
<caption>
<p>Expression levels of LIF and LIFR in the rat retina following acute ocular hypertension. Protein expression of (A and B) LIF and (C and D) LIFR was assessed by western blotting, and the mRNA levels of (E) LIF and (F) LIFR were tested by quantitative PCR assay. Data are expressed as the mean &#x000B1; standard error of the mean. <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01, <sup>&#x0002A;&#x0002A;&#x0002A;</sup>P&lt;0.001, vs. N group. N, normal control; LIF, leukemia inhibitory factor; LIFR, leukemia inhibitory factor receptor; PCR, polymerase chain reaction.</p></caption>
<graphic xlink:href="MMR-12-05-6577-g03.jpg"/></fig>
<fig id="f5-mmr-12-05-6577" position="float">
<label>Figure 5</label>
<caption>
<p>Expression levels of STAT3, Akt, ERK and their corresponding phosphorylated forms in the rat retina following acute ocular hypertension. The protein expression of STAT3, Akt, ERK and their corresponding phosphorylated forms was tested by (A) western blotting, and then (B&#x02013;D) quantitative analysis, respectively. Data are expressed as the mean &#x000B1; standard error of the mean. <sup>&#x0002A;</sup>P&lt;0.05, <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 and <sup>&#x0002A;&#x0002A;&#x0002A;</sup>P&lt;0.001, vs. N group. N, normal control; STAT3, signal transducers and activators of transcription 3; ERK, extracellular signal-regulated kinase; p-, phosphorylated.</p></caption>
<graphic xlink:href="MMR-12-05-6577-g04.jpg"/></fig></floats-group></article>
